Search results
Showing results for
The University of Oxford has today announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the Oxford Vaccine Group.
Immunisation Update Training Programme Tues 10 Nov 2026
Immunisation Update Training Programme Tues 10 Nov 2026
Draft Programme - Immunisation Update Tues 10 Nov 26.pdf (690 KB)
Immunisation Update Training Programme Wed 11 Nov 2026
Immunisation Update Training Programme Wed 11 Nov 2026
Draft Programme - Immunisation Update Wed 11 Nov 26.pdf (687 KB)

